Radiation Force As a Physical Mechanism for Ultrasonic Neurostimulation of the Ex Vivo Retina
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Neurotechnologies and Brain Computer Interface
From Technologies to Market Sample Neurotechnologies and brain computer interface Market and Technology analysis 2018 LIST OF COMPANIES MENTIONED IN THIS REPORT 240+ slides of market and technology analysis Abbott, Ad-tech, Advanced Brain Monitoring, AdvaStim, AIST, Aleva Neurotherapeutics, Alphabet, Amazon, Ant Group, ArchiMed, Artinis Medical Systems, Atlas Neuroengineering, ATR, Beijing Pins Medical, BioSemi, Biotronik, Blackrock Microsystems, Boston Scientific, Brain products, BrainCo, Brainscope, Brainsway, Cadwell, Cambridge Neurotech, Caputron, CAS Medical Systems, CEA, Circuit Therapeutics, Cirtec Medical, Compumedics, Cortec, CVTE, Cyberonics, Deep Brain Innovations, Deymed, Dixi Medical, DSM, EaglePicher Technologies, Electrochem Solutions, electroCore, Elmotiv, Endonovo Therapeutics, EnerSys, Enteromedics, Evergreen Medical Technologies, Facebook, Flow, Foc.us, G.Tec, Galvani Bioelectronics, General Electric, Geodesic, Glaxo Smith Klein, Halo Neurosciences, Hamamatsu, Helius Medical, Technologies, Hitachi, iBand+, IBM Watson, IMEC, Integer, Integra, InteraXon, ISS, Jawbone, Kernel, LivaNova, Mag and More, Magstim, Magventure, Mainstay Medical, Med-el Elektromedizinische Geraete, Medtronic, Micro Power Electronics, Micro Systems Technologies, Micromed, Microsoft, MindMaze, Mitsar, MyBrain Technologies, Natus, NEC, Nemos, Nervana, Neurable, Neuralink, NeuroCare, NeuroElectrics, NeuroLutions, NeuroMetrix, Neuronetics, Neuronetics, Neuronexus, Neuropace, Neuros Medical, Neuroscan, NeuroSigma, NeuroSky, Neurosoft, Neurostar, Neurowave, -
Non-Invasive Neurostimulation Methods for Acute and Preventive Migraine Treatment—A Narrative Review
Journal of Clinical Medicine Review Non-Invasive Neurostimulation Methods for Acute and Preventive Migraine Treatment—A Narrative Review Stefan Evers 1,2 1 Faculty of Medicine, University of Münster, 48153 Münster, Germany; [email protected] 2 Department of Neurology, Lindenbrunn Hospital, 31863 Coppenbrügge, Germany Abstract: Neurostimulation methods have now been studied for more than 20 years in migraine treatment. They can be divided into invasive and non-invasive methods. In this narrative review, the non-invasive methods are presented. The most commonly studied and used methods are vagal nerve stimulation, electric peripheral nerve stimulation, transcranial magnetic stimulation, and transcranial direct current stimulation. Other stimulation techniques, including mechanical stimulation, play only a minor role. Nearly all methods have been studied for acute attack treatment and for the prophylactic treatment of migraine. The evidence of efficacy is poor for most procedures, since no stimulation device is based on consistently positive, blinded, controlled trials with a sufficient number of patients. In addition, most studies on these devices enrolled patients who did not respond sufficiently to oral drug treatment, and so the role of neurostimulation in an average population of migraine patients is unknown. In the future, it is very important to conduct large, properly blinded and controlled trials performed by independent researchers. Otherwise, neurostimulation methods will only play a very minor role in the treatment of migraine. Keywords: neurostimulation; vagal nerve; supraorbital nerve; transcranial magnetic stimulation Citation: Evers, S. Non-Invasive Neurostimulation Methods for Acute and Preventive Migraine 1. Introduction Treatment—A Narrative Review. J. One of the recent innovations in migraine treatment was the detection of several types Clin. -
History, Applications, and Mechanisms of Deep Brain Stimulation
NEUROLOGICAL REVIEW SECTION EDITOR: DAVID E. PLEASURE, MD History, Applications, and Mechanisms of Deep Brain Stimulation Svjetlana Miocinovic, MD, PhD; Suvarchala Somayajula, MD; Shilpa Chitnis, MD, PhD; Jerrold L. Vitek, MD, PhD eep brain stimulation (DBS) is an effective surgical treatment for medication-refractory hypokinetic and hyperkinetic movement disorders, and it is being explored for a variety of other neurological and psychiatric diseases. Deep brain stimulation has been Food and Drug Administration–approved for essential tremor and Parkinson disease and has Da humanitarian device exemption for dystonia and obsessive-compulsive disorder. Neurostimulation is the fruit of decades of both technical and scientific advances in the field of basic neuroscience and functional neurosurgery. Despite the clinical success of DBS, the therapeutic mechanism of DBS re- mains under debate. Our objective is to provide a comprehensive review of DBS focusing on move- ment disorders, including the historical evolution of the technique, applications and outcomes with an overview of the most pertinent literature, current views on mechanisms of stimulation, and de- scription of hardware and programming techniques. We conclude with a discussion of future devel- opments in neurostimulation. JAMA Neurol. 2013;70(2):163-171. Published online November 12, 2012. doi:10.1001/2013.jamaneurol.45 Deep brain stimulation (DBS) has evolved recovery.1-4 New applications continue to as an important therapy for the treat- emerge, encouraged by past successes and ment of essential tremor, Parkinson dis- the fact that DBS effects are reversible al- ease (PD), and dystonia, and it is also lowing exploration of new targets and ap- emerging for the treatment of medication- plications not previously possible with le- refractory psychiatric disease. -
State-Of-The-Art BCI Device Technology
State-of-the-Art BCI Device Technology Jose L. Contreras-Vidal, Ph.D. University of Houston STATE OF THE ART PATIENT BCI SOLUTIONS (CORTICAL INVASIVE AND NONINVASIVE, PERIPHERAL) Jose L Contreras-Vidal, PhD Hugh Roy and Lillie Cranz Cullen University Professor Department of Electrical & Computer Engineering University of Houston http://www.ee.uh.edu/faculty/contreras-vidal https://www.facebook.com/UHBMIST Scope • “Neuroprostheses that interface with the central or peripheral nervous system to restore lost motor or sensory capabilities” (FDA’s working definition of BCI) • BCI Devices for Patients with Paralysis and Amputation • Cortical (invasive and noninvasive) and Peripheral • Human investigational studies of BCI devices reported in clinicaltrials.gov Working definition of BCI systems Neural interface – Recording electrode 1 3 Prosthetic, exoskeleton, robotic or virtual effector (usually + shared control) 2 Feedback system – Definitions: Neural stimulator 1 – interface, physical/virtual effector Closed loop 2 – interface, physical effector feedback 3 – interface, feedback Sensor – response system Neural Interface to prosthetic, exoskeleton, robotic or virtual effector (definition 1) Research Clinical Studies Cleared/Approved Myoelectric prosthetic High DOF prosthetic, myoelectric + shared control Invasive cortical interface EEG interface BCI systems Implantable myoelectric sensor Exoskeleton Novel cortical interface * Dry contact EEG * * Not reviewed here. Peripheral nerve sensors * Neural Interface to prosthetic, exoskeleton, robotic -
Auditory and Visual System White Matter Is Differentially Impacted by Normative Aging in Macaques
The Journal of Neuroscience, November 11, 2020 • 40(46):8913–8923 • 8913 Behavioral/Cognitive Auditory and Visual System White Matter Is Differentially Impacted by Normative Aging in Macaques Daniel T. Gray,1,2 Nicole M. De La Peña,1,2 Lavanya Umapathy,3 Sara N. Burke,4 James R. Engle,1,2 Theodore P. Trouard,2,5 and Carol A. Barnes1,2,6 1Division of Neural System, Memory and Aging, University of Arizona, Tucson, Arizona 85724, 2Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona 85724, 3Electrical and Computer Engineering, University of Arizona, Tucson, Arizona 85724, 4Evelyn F. McKnight Brain Institute, University of Florida, Gainesville, Florida 32609, 5Department of Biomedical Engineering, University of Arizona, Tucson, Arizona 85724, and 6Departments of Psychology, Neurology and Neuroscience, University of Arizona, Tucson, Arizona 85724 Deficits in auditory and visual processing are commonly encountered by older individuals. In addition to the relatively well described age-associated pathologies that reduce sensory processing at the level of the cochlea and eye, multiple changes occur along the ascending auditory and visual pathways that further reduce sensory function in each domain. One fundamen- tal question that remains to be directly addressed is whether the structure and function of the central auditory and visual systems follow similar trajectories across the lifespan or sustain the impacts of brain aging independently. The present study used diffusion magnetic resonance imaging and electrophysiological assessments of auditory and visual system function in adult and aged macaques to better understand how age-related changes in white matter connectivity at multiple levels of each sensory system might impact auditory and visual function. -
XTRACT - Standardised Protocols for Automated Tractography in the Human and Macaque Brain”
Supplementary Materials for “XTRACT - Standardised protocols for automated tractography in the human and macaque brain” Warrington S1, Bryant KL2,3, Khrapitchev AA4, Sallet J5, Charquero-Ballester M6, Douaud G3, Jbabdi S3*, Mars RB2,3*, Sotiropoulos SN1,3,7* 1Sir Peter Mansfield Imaging Centre, School of Medicine, University of Nottingham, UK 2Donders Institute for Brain, Cognition, & Behaviour, Radboud University NiJmegen, NiJmegen, Netherlands 3FMRIB, Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK 4CRUK and MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, UK 5Wellcome Centre for Integrative Neuroimaging - Department of Experimental Psychology, University of Oxford, UK 6Department of Psychiatry, University of Oxford, UK 7National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Queens Medical Centre, Nottingham, UK *Equal contribution Corresponding author: Stamatios Sotiropoulos ([email protected]) Thiebaut de Wakana1 Catani2 Hua3 Zhang4 Yendiki6 de Groot7 Wassermann8 Tract Schotten5 (N=4) (N=12) (N=28) (N=10) (N=67) (N=60) (N=97) (N=40) Acoustic Radiation P Anterior Commissure P P Anterior Thalamic P P P P P Radiation P (Arcuate and Arcuate Fasciculus P anterior, long P and posterior segments) Cingulum subsection: P P P P P Dorsal Cingulum subsection: P P P P P P P P Peri-genual Cingulum subsection: Temporal P (Rostrum, rostral Corpus Collosum -
Focused Ultrasound for Noninvasive, Focal Pharmacologic Neurointervention
fnins-14-00675 July 14, 2020 Time: 17:3 # 1 REVIEW published: 14 July 2020 doi: 10.3389/fnins.2020.00675 Focused Ultrasound for Noninvasive, Focal Pharmacologic Neurointervention Jeffrey B. Wang†, Tommaso Di Ianni†, Daivik B. Vyas, Zhenbo Huang, Sunmee Park, Niloufar Hosseini-Nassab, Muna Aryal and Raag D. Airan* Neuroradiology Division, Department of Radiology, Stanford University, Stanford, CA, United States A long-standing goal of translational neuroscience is the ability to noninvasively deliver therapeutic agents to specific brain regions with high spatiotemporal resolution. Focused ultrasound (FUS) is an emerging technology that can noninvasively deliver energy up the order of 1 kW/cm2 with millimeter and millisecond resolution to any point in the human brain with Food and Drug Administration-approved hardware. Although Edited by: FUS is clinically utilized primarily for focal ablation in conditions such as essential tremor, Victor Frenkel, recent breakthroughs have enabled the use of FUS for drug delivery at lower intensities University of Maryland, Baltimore, (i.e., tens of watts per square centimeter) without ablation of the tissue. In this review, we United States present strategies for image-guided FUS-mediated pharmacologic neurointerventions. Reviewed by: Vassiliy Tsytsarev, First, we discuss blood–brain barrier opening to deliver therapeutic agents of a variety University of Maryland, College Park, of sizes to the central nervous system. We then describe the use of ultrasound-sensitive United States Graeme F. Woodworth, nanoparticles to noninvasively deliver small molecules to millimeter-sized structures University of Maryland, Baltimore, including superficial cortical regions and deep gray matter regions within the brain United States without the need for blood–brain barrier opening. -
Wireless, Battery-Free, and Fully Implantable Electrical
Burton et al. Microsystems & Nanoengineering (2021) 7:62 Microsystems & Nanoengineering https://doi.org/10.1038/s41378-021-00294-7 www.nature.com/micronano ARTICLE Open Access Wireless, battery-free, and fully implantable electrical neurostimulation in freely moving rodents Alex Burton1,SangMinWon 2, Arian Kolahi Sohrabi3, Tucker Stuart1, Amir Amirhossein1,JongUkKim4, ✉ ✉ ✉ Yoonseok Park 4, Andrew Gabros3,JohnA.Rogers 4,5,6,7,8,9 , Flavia Vitale10 ,AndrewG.Richardson 3 and ✉ Philipp Gutruf 1,11,12 Abstract Implantable deep brain stimulation (DBS) systems are utilized for clinical treatment of diseases such as Parkinson’s disease and chronic pain. However, long-term efficacy of DBS is limited, and chronic neuroplastic changes and associated therapeutic mechanisms are not well understood. Fundamental and mechanistic investigation, typically accomplished in small animal models, is difficult because of the need for chronic stimulators that currently require either frequent handling of test subjects to charge battery-powered systems or specialized setups to manage tethers that restrict experimental paradigms and compromise insight. To overcome these challenges, we demonstrate a fully implantable, wireless, battery-free platform that allows for chronic DBS in rodents with the capability to control stimulation parameters digitally in real time. The devices are able to provide stimulation over a wide range of frequencies with biphasic pulses and constant voltage control via low-impedance, surface-engineered platinum electrodes. The devices utilize off-the-shelf components and feature the ability to customize electrodes to enable 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; broad utility and rapid dissemination. Efficacy of the system is demonstrated with a readout of stimulation-evoked neural activity in vivo and chronic stimulation of the medial forebrain bundle in freely moving rats to evoke characteristic head motion for over 36 days. -
Combined Occipital and Supraorbital Neurostimulation for the Treatment of Chronic Migraine Headaches: Initial Experienceceph 1996 1..13
doi:10.1111/j.1468-2982.2009.01996.x Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experienceceph_1996 1..13 KL Reed1, SB Black2, CJ Banta II3 &KRWill1 1Department of Anesthesiology, Presbyterian Hospital of Dallas, 2Medical Director of Neurology, Baylor University Medical Center of Dallas, and 3Department of Orthopedic Surgery, Presbyterian Hospital of Dallas, Dallas, TX, USA Reed KL, Black SB, Banta CJ II & Will KR. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial expe- rience. Cephalalgia 2009. London. ISSN 0333-1024 A novel approach to the treatment of chronic migraine headaches based on neurostimulation of both occipital and supraorbital nerves was developed and reduced to clinical practice in a series of patients with headaches unresponsive to currently available therapies. Following positive trials, seven patients with chronic migraine and refractory chronic migraine headaches had permanent combined occipital nerve–supraorbital nerve neurostimulation systems implanted. The relative responses to two stimulation programs were evaluated: one that stimulated only the occipital leads and one that stimulated both the occipital and supraorbital leads together. With follow-up ranging from 1 to 35 months all patients reported a full therapeutic response but only to combined supraorbital–occipital neurostimulation. Occipital nerve stimulation alone pro- vided a markedly inferior and inadequate response. Combined occipital nerve– supraorbital nerve neurostimulation systems may provide effective treatment for patients with chronic migraine and refractory chronic migraine headaches. For patients with chronic migraine headaches the response to combined systems appears to be substantially better than occipital nerve stimulation alone. ᮀMigraine, chronic migraine, refractory migraine, peripheral nerve stimulation, occipi- tal nerve stimulation, supraorbital nerve stimulation Kenneth L. -
10 Things to Know About Neuromodulation. Minimally Invasive Procedures to Reduce Or Alleviate Pain
NORTH AMERICAN NEUROMODULATION SOCIETY 4700 W. Lake Avenue Glenview, IL 60025 www.neuromodulation.org Rubenstein Public Relations Contact: Eve McGrath Tel: 212-843-8490 Email: [email protected] FOR IMMEDIATE RELEASE 10 Things to Know About Neuromodulation Minimally Invasive Procedures to Reduce or Alleviate Pain NEW YORK – February 24, 2010 – Robert Foreman, Ph.D., president of the North American Neuromodulation Society (NANS), stated, “Neuromodulation is among the most rapidly growing fields in medicine today. It can help to relieve chronic back pain, pain from cancer and other nerve injuries, pain from Complex Regional Pain Syndrome (CRPS) and Reflex Sympathetic Dystrophy (RSD) greatly improving the quality of life for patients.” Neuromodulation encompasses the application of targeted electrical, chemical and biological technologies to the nervous system in order to improve function and quality of life. The appropriate therapy (low level electrical pulses or micro-doses of medicine) are targeted to nerves along the spinal cord to block pain signals to the brain According to Joshua Prager, MD, MS, former president of NANS, “Neuromodulation can give people their lives back. Patients have gone from wheelchairs back to the tennis court, back to the sidelines of their children’s soccer games, back to their jobs. There are few treatments that can improve the activity level and the psychological outlook of a patient in pain like neuromodulation techniques.” NANS has compiled ten things everyone should know about neuromodulation: 1. Neuromodulation alleviates or lessens pain without putting patients into a “drug fog.” By relieving pain with neuro-stimulation or a drug-delivery system, that provides micro- doses of medicine, the patient can avoid some side effects, including excessive sedation or clouding of thoughts. -
Neurostimulation Documentation
Dorsal Column Spinal Cord Neurostimulation or Depth Brain Neurostimulation for Chronic Intractable Pain Documentation Worksheet (Based on National Coverage Determination (NCD) 160.7 for Electrical Nerve Stimulators) Patient Name:_______________________________________________Procedure:___________________________________________________________ Diagnoses/Clinical Reason(s) for implanting neurostimulator:_____________________________________________________________________________ Describe other treatment modalities that have been tried and did not prove satisfactory, or were judged unsuitable or contraindicated for the patient, including trial electrical nerve stimulation [e.g., transcutaneous (TENS), percutaneous (PENS)]. NOTE: Include applicable physician office documentation of previous treatment(s) in the facility medical record. o Analgesics/NSAIDS and duration of treatment:____________________________________________________________________________ __________________________________________________________________________________________________________________ o Supervised physical therapy with frequency and duration:___________________________________________________________________ __________________________________________________________________________________________________________________ o Therapeutic spinal injections:__________________________________________________________________________________________ __________________________________________________________________________________________________________________ -
A Review of Neuromodulation in the Neurorehabilitation
l of rna Neu ou ro Yin and Slavin, Int J Neurorehabilitation Eng 2015, 2:1 J r l e a h a n b International DOI: 10.4172/2376-0281.1000151 o i i t l i t a a n t r i o e t n n I ISSN: 2376-0281 Journal of Neurorehabilitation Review Article Open Access A Review of Neuromodulation in the Neurorehabilitation Dali Yin and Konstantin V Slavin* Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL, USA Abstract For many years, invasive neuromodulation has been used in neurorehabilitation, mainly in treatment of movement disorders and various psychiatric conditions. Use of deep brain stimulation and other implanted electrical stimulators is being explored in other conditions, such as stroke, traumatic brain injury and spinal cord injury. This paper provides a review of the possible role of Neuromodulation in neurorehabilitation and highlights some of its applications for patients with various neurological conditions. Since most of the existing findings are based on animal studies, preliminary data, case reports and poor-controlled studies, further investigations including research and clinical trials are necessary to increase the applications of neurostimulation in the field of neurorehabilitation. Keywords: Neuromodulation; Neurorehabilitation; Stroke; rehabilitation constantly improves motor function in ratsfollowing Traumatic brain injury; Spinal cord injury; Epilepsy motor cortex injury [10-11]. Introduction Motor Cortex Stimulation Neurorehabilitation is a complicated medical process; its goal is to A small randomized clinical trial [n=24] found that Motor Cortex help patients to recover from injuries or abnormalities in the Central Stimulation [MCS] lead to motor and functional improvements Nervous System [CNS], and to compensate for functional deficits if [difference of Fugl-Meyer motor scores in estimated means = 3.8, p = possible.